Brendan Hannah - Jun 18, 2025 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
CBO, COO & CCO
Signature
/s/ Brendan Hannah
Stock symbol
QNCX
Transactions as of
Jun 18, 2025
Transactions value $
$50,000
Form type
4
Date filed
6/23/2025, 08:48 AM
Previous filing
Feb 11, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hannah Brendan CBO, COO & CCO C/O QUINCE THERAPEUTICS, INC., 611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO /s/ Brendan Hannah 2025-06-20 0001929422

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Shares Award $45.3K +37.7K +12.73% $1.20 334K Jun 18, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Warrants Award $4.72K +37.7K $0.13 37.7K Jun 18, 2025 Common Shares 37.7K $1.20 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.